Mammography-Based AI Breast Cancer Risk Prediction
Customize your policy alerts
Sign up for all premerabluecrossofwashington policy alerts
Know when premerabluecrossofwashington releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs mammography-based artificial intelligence software that estimates an individual's 5-year breast cancer risk from bilateral screening mammography. The service is considered investigational because evidence is insufficient to demonstrate effectiveness.
A new policy was established stating that mammography-based AI risk prediction software used with bilateral screening mammography to estimate 5-year breast cancer risk is investigational.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.